InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
LPS-EB (LPS from E. coli O111:B4) | Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANopto... | 2023 | J Biol Chem. | Sharma B.R. et al. | DOI: 10.1016/j.jbc.2023.105141 |
FLA-ST (Standard or Ultrapure) | Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANopto... | 2023 | J Biol Chem. | Sharma B.R. et al. | DOI: 10.1016/j.jbc.2023.105141 |
Poly(dA:dT) | Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANopto... | 2023 | J Biol Chem. | Sharma B.R. et al. | DOI: 10.1016/j.jbc.2023.105141 |
R848 (Resiquimod) | A novel Toll-like receptor 7/8–specific antagonist E6742 Ameliorates clinical... | 2023 | Eur J Pharmacol. | Ishizaka S.T. et al. | DOI: 10.1016/j.ejphar.2023.175962 |
CL097 | A novel Toll-like receptor 7/8–specific antagonist E6742 Ameliorates clinical... | 2023 | Eur J Pharmacol. | Ishizaka S.T. et al. | DOI: 10.1016/j.ejphar.2023.175962 |
Pam3CSK4 | A novel Toll-like receptor 7/8–specific antagonist E6742 Ameliorates clinical... | 2023 | Eur J Pharmacol. | Ishizaka S.T. et al. | DOI: 10.1016/j.ejphar.2023.175962 |
Poly(I:C) HMW | A novel Toll-like receptor 7/8–specific antagonist E6742 Ameliorates clinical... | 2023 | Eur J Pharmacol. | Ishizaka S.T. et al. | DOI: 10.1016/j.ejphar.2023.175962 |
ODN 2006 (ODN 7909) | A novel Toll-like receptor 7/8–specific antagonist E6742 Ameliorates clinical... | 2023 | Eur J Pharmacol. | Ishizaka S.T. et al. | DOI: 10.1016/j.ejphar.2023.175962 |
FLA-BS (Standard or Ultrapure) | A novel Toll-like receptor 7/8–specific antagonist E6742 Ameliorates clinical... | 2023 | Eur J Pharmacol. | Ishizaka S.T. et al. | DOI: 10.1016/j.ejphar.2023.175962 |
ODN 2395 VacciGrade™ | Exposure to unmethylated CpG oligonucleotides disrupts blood pressure circadi... | 2023 | Am J Physiol Heart Circ Physiol. | Bradshaw J.L. et al. | DOI: 10.1152/ajpheart.00154.2023 |
Primocin® | Protocol to establish an oviduct epithelial cell line derived from Gallus gal... | 2023 | STAR Protoc. | Loubser C. & Nikitina N.V. | DOI: 10.1016/j.xpro.2023.102495 |
Puromycin | Glioblastoma vascular plasticity limits effector T-cell infiltration and is b... | 2023 | Cancer Immunol Res. | Qin Z. et al. | DOI: 10.1158/2326-6066.CIR-22-0872 |
Blasticidin | RNA-binding protein CCDC137 activates AKT signaling and promotes hepatocellul... | 2023 | J Exp Clin Cancer Res. | Tao S. et al. | DOI: 10.1186/s13046-023-02749-3 |
Puromycin | RNA-binding protein CCDC137 activates AKT signaling and promotes hepatocellul... | 2023 | J Exp Clin Cancer Res. | Tao S. et al. | DOI: 10.1186/s13046-023-02749-3 |
Human TLR7 Reporter HEK293 Cells (NF-κB) | In vitro alternative for reactogenicity assessment of outer membrane vesicle ... | 2023 | Sci Rep. | Molenaar-de Backer M.W.A. et al. | DOI: 10.1038/s41598-023-39908-7 |
Human NOD2 Reporter HEK293 Cells (NF-κB) | In vitro alternative for reactogenicity assessment of outer membrane vesicle ... | 2023 | Sci Rep. | Molenaar-de Backer M.W.A. et al. | DOI: 10.1038/s41598-023-39908-7 |
HEK-Blue™ Null2 Cells | In vitro alternative for reactogenicity assessment of outer membrane vesicle ... | 2023 | Sci Rep. | Molenaar-de Backer M.W.A. et al. | DOI: 10.1038/s41598-023-39908-7 |
HEK-Blue™ hNOD1 | In vitro alternative for reactogenicity assessment of outer membrane vesicle ... | 2023 | Sci Rep. | Molenaar-de Backer M.W.A. et al. | DOI: 10.1038/s41598-023-39908-7 |
Human TLR3 Reporter HEK293 Cells (NF-κB) | In vitro alternative for reactogenicity assessment of outer membrane vesicle ... | 2023 | Sci Rep. | Molenaar-de Backer M.W.A. et al. | DOI: 10.1038/s41598-023-39908-7 |
Human TLR2 Reporter HEK293 Cells (NF-κB) | In vitro alternative for reactogenicity assessment of outer membrane vesicle ... | 2023 | Sci Rep. | Molenaar-de Backer M.W.A. et al. | DOI: 10.1038/s41598-023-39908-7 |